qwertyuiopasdfghjklzxcvbnmqwerty uiopasdfghjklzxcvbnmqwertyuiopasd fghjklzxcvbnmqwertyuiopasdfghjklzx cvbnmqwertyuiopasdfghjklzxcvbnmq wertyuiopasdfghjklzxcvbnmqwertyui opasdfghjklzxcvbnmqwertyuiopasdfg hjklzxcvbnmqwertyuiopasdfghjklzxc vbnmqwertyuiopasdfghjklzxcvbnmq wertyuiopasdfghjklzxcvbnmqwertyui opasdfghjklzxcvbnmqwertyuiopasdfg NIFTY OUTLOOK hjklzxcvbnmqwertyuiopasdfghjklzxc REPORT vbnmqwertyuiopasdfghjklzxcvbnmq 11 Sep 2017 wertyuiopasdfghjklzxcvbnmqwertyui opasdfghjklzxcvbnmqwertyuiopasdfg hjklzxcvbnmrtyuiopasdfghjklzxcvbn mqwertyuiopasdfghjklzxcvbnmqwert yuiopasdfghjklzxcvbnmqwertyuiopas th
11th Sep 2017
NIFTY
NIFTY FUT : PIVOT : 9943
R1:9975 S1:9921
R2:10010 S2:9892
R3:10055 S3:9864
NIFTY INTRADAY CHART NIFTY OUTLOOK Nifty is likely to open with a gap up opening. Momentum indicators are indicating towards bullish rule ahead. Positional traders are advised to keep their stop loss at 9900 for their longs while for contra it should be placed at 10,029.Intraday traders are advised to adopt buy on dips strategy for the day. Strategy: long nifty around 9970 tgt 10000 sl 9935
Name
Current Value
Change
% Chg
Open
High
Low
FTSE 100 (Sep 8)
7,377.60
-19.38
-0.26
7,396.98
7,396.98
7,358.42
CAC 40 (Sep 8)
5,113.49
-1.13
-0.02
5,099.31
5,117.89
5,086.51
12,303.98
7.35
0.06
12,261.81
12,321.61
12,245.33
19,555.32
280.5
1.43
19,441.39
19,567.03
19,437.14
3,234.76
6.2
0.19
3,239.29
3,240.90
3,232.49
27,934.68
266.21
0.95
27,877.69
27,976.98
27,859.00
Taiwan Weighted (Sep 11)
10,577.19
-32.76
-0.31
10,630.16
10,656.25
10,569.52
SGX Nifty (Sep 11)
10,013.00
66
0.66
9,942.00
10,018.50
9,933.50
DAX (Sep 8) Nikkei 225 (Sep 11) Straits Times (Sep 11) Hang Seng (Sep 11)
WWW.EQUITYRESEARCHLAB.COM
11th Sep 2017
CORPORATE NEWS -Aurobindo Pharma gets US FDA nod for pelvic inflammation drug Metronidazole tablet -Deep Industries has received letter of award (LOA) from ONGC for Ankleshwar asset extension worth Rs 2.6 crore -Oriental Bank of Commerce cuts one-year MCLR to 8.40 percent -Lanco Infra has decided to exit its real estate investment to refocus on its core business -Coal India to initiate long term supply contracts to supply 40mn tonnes under the Shakti scheme -Wind developers upset over Karantaka tariff order that reduces the feed in tariff for discoms from Rs 4.5 per KWH to 3.74 per KWH -Bharti Airtel, Idea Cellular in focus- Department of Telecommunications makes telecom gear testing must from October 2018 -Commodity futures - SEBI mulls lifting decade old ban on tur, urad futures -Tata Sons to reduce cross-holdings in Tata Chemicals, Tata Power: BS -CRPL board may meet this week to take a call on 169 McDonald’s stores: BS -IndiGo (part of InterGlobe Aviation) eyes on wet lease to cash in on winter traffic: BS -Airtel in talks with handset firms for Rs 2500 4G smartphone: BS -Zee Entertainment eyes HD English movies with &Prive: ET -Future Group looking to buyout Hypercity: ET -Century Textiles may explore merger with Grasim after sale of paper division: BloombergQuint -Shapoorji Pallonji, SSG Capital plan joint bid for Jyoti Structures acquisition: Mint -SEBI to reduce mutual funds scheme by half -China to ban sale of fossil fuel run cars -ONGC's gas production plan from KG basin may miss June 2019 deadline: Mint -Pitti Laminations gets shareholder nod to reappoint Sharad B Pitti as chairman & MD -SC declines bail for Unitech MD Sanjay Chandra for not delivering flats: CNN-News18 -Idea says as directed by NCLT, shareholders, creditors to meet to consider amalgamation among Vodaafone Mobile Services, Vodafone India & Company on October 12-Telecom Commission sources say Rs 3,100 crore from USOF Fund will be used to set up about 4100 towers for uncovered villages; contract has gone to Bharti Airtel
WWW.EQUITYRESEARCHLAB.COM
11th Sep 2017
ERL RESEARCH TEAM Member Name
Designation
Mr. Tuhinanshu Jain Mr. Manish Bimal Mr. Anand Sharma Mr. Sumit Sahu
Research Head Sr. Research Analyst Research Analyst Research Analyst
DISCLAIMER The information and views in this report, our website & all the service we provide are believed to be reliable, but we do not accept any responsibility (or liability) for errors of fact or opinion. Users have the right to choose the product/s that suits them the most. Investment in Stocks has its own risks. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. We, however, do not vouch for the accuracy or the completeness thereof. This material is for personal information and we are not responsible for any loss incurred based upon it & takes no responsibility whatsoever for any financial profit s or loss which may arise from the recommendations above. The stock price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. Equity Research Lab does not purport to be an invitation or an offer to buy or sell any financial instrument. Analyst or any person related to Equity Research Lab might be holding positions in the stocks recommended. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Any surfing and reading of the information is the acceptance of this disclaimer. Our Clients (Paid or Unpaid), any third party or anyone else have no rights to forward or share our calls or SMS or Report or Any Information Provided by us to/with anyone which is received directly or indirectly by them. If found so then Serious Legal Actions can be taken. Any surfing and reading of the information is the acceptance of this disclaimer. ALL RIGHTS RESERVED.
WWW.EQUITYRESEARCHLAB.COM